All AstraZeneca articles
-
NewsUK’s failure to retain and scale science and technology causing economy to bleed out, warns Lords Committee
The UK’s failure to retain and scale its science and technology companies has now reached crisis point and is causing the UK economy to bleed out, warns a damning report.
-
NewsSummer studentship: Shen explores how a novel peptide can destabilise the outer membrane of E. coli
Li Shen reports back on his AMI-sponsored summer studentship which investigated a novel antibiotic adjuvant at the Centre for Bacterial Resistance Biology, Imperial College London.
-
NewsAI could accelerate protein engineering – key for developing new medicines
An AI approach developed by researchers from the University of Sheffield and AstraZeneca could make it easier to design proteins needed for new treatments.
-
NewsClinical trial underway for potential Long COVID treatment
A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid.
-
NewsAsthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery
A recent study suggests that patients with chronic rhinosinusitis, who had undergone endoscopic sinus surgery, have a higher chance of undergoing revision sinus surgery that removes nasal polyps if they have asthma and are using antibiotics.
-
NewsResearchers investigate bunyaviruses and picornaviruses in bid to stave off next pandemic
A $13 million per year grant will enable researchers to accelerate their investigations of bunyaviruses, which include life-threatening respiratory and hemorrhagic fever viruses, and picornaviruses, notably enterovirus D68.
-
NewsNew antibiotic kills pathogenic bacteria, but spares healthy gut microbes
Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut.
-
NewsScientists build human lungs in dish to test drugs
Scientists have developed a step-by-step blueprint to create advanced human lung models in the lab, which they say will accelerate the discovery and development of new drugs and reduce reliance on animal testing.
-
NewsChange in genetics of SARS-CoV-2 evolved to counter weakness caused by the virus’s initial mutation
Researchers at Johns Hopkins Medicine say their new studies suggest that the first pandemic-accelerating mutation in the SARS-CoV-2 virus, which causes COVID-19, evolved as a way to correct vulnerabilities caused by the mutation that started the SARS-CoV-2 pandemic.